» Articles » PMID: 36553532

The Sum of Two Halves May Be Different from the Whole-Effects of Splitting Sequencing Samples Across Lanes

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2022 Dec 23
PMID 36553532
Authors
Affiliations
Soon will be listed here.
Abstract

The advances in high-throughput sequencing (HTS) have enabled the characterisation of biological processes at an unprecedented level of detail; most hypotheses in molecular biology rely on analyses of HTS data. However, achieving increased robustness and reproducibility of results remains a main challenge. Although variability in results may be introduced at various stages, e.g., alignment, summarisation or detection of differential expression, one source of variability was systematically omitted: the sequencing design, which propagates through analyses and may introduce an additional layer of technical variation. We illustrate qualitative and quantitative differences arising from splitting samples across lanes on bulk and single-cell sequencing. For bulk mRNAseq data, we focus on differential expression and enrichment analyses; for bulk ChIPseq data, we investigate the effect on peak calling and the peaks' properties. At the single-cell level, we concentrate on identifying cell subpopulations. We rely on markers used for assigning cell identities; both smartSeq and 10× data are presented. The observed reduction in the number of unique sequenced fragments limits the level of detail on which the different prediction approaches depend. Furthermore, the sequencing stochasticity adds in a weighting bias corroborated with variable sequencing depths and (yet unexplained) sequencing bias. Subsequently, we observe an overall reduction in sequencing complexity and a distortion in the biological signal across technologies, experimental contexts, organisms and tissues.

References
1.
Thurmond J, Goodman J, Strelets V, Attrill H, Gramates L, Marygold S . FlyBase 2.0: the next generation. Nucleic Acids Res. 2018; 47(D1):D759-D765. PMC: 6323960. DOI: 10.1093/nar/gky1003. View

2.
Steward C, Parker A, Minassian B, Sisodiya S, Frankish A, Harrow J . Genome annotation for clinical genomic diagnostics: strengths and weaknesses. Genome Med. 2017; 9(1):49. PMC: 5448149. DOI: 10.1186/s13073-017-0441-1. View

3.
McCarthy D, Chen Y, Smyth G . Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012; 40(10):4288-97. PMC: 3378882. DOI: 10.1093/nar/gks042. View

4.
Holmstrom S, Hautaniemi S, Hakkinen A . POIBM: batch correction of heterogeneous RNA-seq datasets through latent sample matching. Bioinformatics. 2022; 38(9):2474-2480. PMC: 9048693. DOI: 10.1093/bioinformatics/btac124. View

5.
Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View